Christopher Regna

Background

About Christopher Regna

Experienced Finance professional with a highly diverse background in industries and skills focused on manufacturing, including, specialty chemicals, medical devices, traditional small molecule pharmaceutical, and large molecule biologics both microbial and mammalian cell expression systems. My background/ prior experience includes information technology, 3rd party contract manufacturing and material sourcing, Foreign Trade Zone operations and US Customs law, strategic planning, and business process re-engineering. I have been actively involved in helping BMS to build it's Biologic's capabilities, including the construction of the Devens, MA large scale cell culture facility, approximately $1B investment, FDA approved in 2012 and a recently completed site expansion to include small scale disposable cell culture mfg. In addition we just recently announced completed construction of a new large scale drug substance manufacturing facility in Dublin, Ireland, approximately $1B investment. Currently overseeing global mfg. both internal & external for both biologic's and traditional small molecule. In addition I currently lead the Finance BD team supporting BD activities with-in Global Manufacturing and I remain the Finance Lead for the BMS/Celgene integration for Global Mfg. Supply & Development